BRIEF-Ensysce Biosciences Says Received Notice From Nasdaq Stating Co Was Not In Compliance With Nasdaq Listing Rule 5550(A)(2)

Reuters03-29

March 29 (Reuters) - Ensysce Biosciences Inc :

* ENSYSCE BIOSCIENCES - ON MARCH 27, RECEIVED NOTICE FROM NASDAQ STATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5550$(A)$(2)

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2423625144?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-29 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2423625144","market":"us","top_or_hot":-1,"title":"BRIEF-Ensysce Biosciences Says Received Notice From Nasdaq Stating Co Was Not In Compliance With Nasdaq Listing Rule 5550(A)(2)","media":"Reuters","content":"<html><body><p>March 29 (Reuters) - Ensysce Biosciences Inc   :</p><p>   * ENSYSCE BIOSCIENCES - ON MARCH 27, RECEIVED NOTICE FROM NASDAQ STATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5550<a href=\"https://laohu8.com/S/A\">$(A)$</a>(2)</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ensysce Biosciences Says Received Notice From Nasdaq Stating Co Was Not In Compliance With Nasdaq Listing Rule 5550(A)(2)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ensysce Biosciences Says Received Notice From Nasdaq Stating Co Was Not In Compliance With Nasdaq Listing Rule 5550(A)(2)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-29 21:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 29 (Reuters) - Ensysce Biosciences Inc   :   * ENSYSCE BIOSCIENCES - ON MARCH 27, RECEIVED NOTICE FROM NASDAQ STATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5550$(A)$(2)Source ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SQQQ","symbol_name":"纳指三倍做空ETF","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2423625144","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2423625144","pubTimestamp":1711719316,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 29 (Reuters) - Ensysce Biosciences Inc   :   * ENSYSCE BIOSCIENCES - ON MARCH 27, RECEIVED NOTICE FROM NASDAQ STATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5550(A)(2)Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SQQQ":"纳指三倍做空ETF","BK4588":"碎股","NDAQ":"纳斯达克OMX交易所","A":"安捷伦科技","QID":"纳指两倍做空ETF","BK4112":"金融交易所和数据","LU2092937221.SGD":"Blackrock Circular Economy A2 SGD-H","ENSC":"Ensysce Biosciences Inc.","LU1165135440.EUR":"BNP Paribas Aqua Classic Cap EUR",".IXIC":"NASDAQ Composite","TQQQ":"纳指三倍做多ETF","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4567":"ESG概念","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","BK4585":"ETF&股票定投概念","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","PSQ":"纳指反向ETF","LU1543694498.USD":"法巴水资源基金RH MD Dis","BK4139":"生物科技","LU2041044095.USD":"Blackrock Circular Economy A2 USD","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","BK4121":"生命科学工具和服务"},"translate_title":"简介-Ensysce Biosciences表示收到纳斯达克的通知，称Co不符合纳斯达克上市规则5550（A）（2）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"A":1,".IXIC":1,"NDAQ":1,"ENSC":0.9,"TQQQ":0.6,"SQQQ":0.6,"QQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"NQmain":0.6,"MNQmain":0.6},"content_text":"March 29 (Reuters) - Ensysce Biosciences Inc   :   * ENSYSCE BIOSCIENCES - ON MARCH 27, RECEIVED NOTICE FROM NASDAQ STATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5550$(A)$(2)Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2423625144"}